phone link
+44 (0)1462 440 084
email link
info@quanticate.com
About
Who We Are
Who We Serve
Emerging Biotechs and Pharma
Mid-Large Pharma and Biotechs
Medical Device
Careers
What is a Data-Focused CRO?
News
Services
Biostatistics
Biostatistical Consulting
Data Quality Oversight
Bayesian Methods in Clinical Design
PK Analysis
Statistical Programming
Clinical Data Management
Clinical Data Visualisations
Medical Writing
Clinical Study Report
Protocol Development
Clinical Trial Transparency
Lay Summaries
Clinical Trial Registration & Result Disclosures
Data & Document Anonymisation
Pharmacovigilance
Pharmacovigilance Safety Database
Innovations
Phase I Standardisations
Tables & Listings Automation
SDTM Automations
Artificial Intelligence
Expertise
Therapeutic Experience
Functional Service Provision
Real World Evidence
ISS ISE Services
Rescue Studies
Clinical Trial Phases
CDISC Services & Mapping
Resources
Whitepapers & Webinars
Case Studies
Blog
Podcast
Videos
Contact
Contact Us
Global CRO
Submit RFI
Search Results for:
Search
Content Title
Description
More Results
Home
Resources
Blog
Blog
Topics
Regulatory Requirements
Clinical Data Management
FDA
Clinical Trials
SAS Programming
Clinical Study Design
Clinical Programming
Biostatistics Consulting
CDISC
Statistical Programming
Adverse Events (AEs)
Good Clinical Practice (GCP)
Statistical Consultancy
European Medicines Agency
Statistics
Oncology
Phase I Studies
Real World Data
Regulatory Submission
SAS
Case Report Form (CRF)
Clinical Trial Documentation
Data Integrity
Pharmacokinetics and Pharmacodynamic
Risk Based Monitoring
SDTM
CDISC SDTM
Clinical Data Services
Clinical Data Storage
Clinical Study Report
Most Popular Articles
The ALCOA++ Principles for Data Integrity in Clinical Trials
August 28, 2025
A Guide to CDISC SDTM Standards and Domains
July 29, 2024
A Guide to Phase 1 Clinical Trial Designs
September 18, 2023
Longitudinal Observational Data in Paediatric Disease Registries
By Statistical Consultancy Team
September 11, 2026
How longitudinal observational data from registries can inform growth, maturation and safety analyses, with key risks around bias and follow-up.
Learn more
Tipping Point Analysis in Clinical Trials
By Statistical Consultancy Team
September 9, 2026
Understand tipping point analysis in clinical trials, including MAR, MNAR, delta shifts, endpoint types, and key limitations.
Learn more
Clinical Trial Planning and Design: What to Plan Before Execution
By Statistical Consultancy Team
September 4, 2026
See how clinical trial planning and design connects the research question with population, endpoints, comparator choice, analysis and feasibility.
Learn more
What is a Clinical Development Plan (CDP) and What Should It Include?
By Statistical Consultancy Team
September 2, 2026
Understand how a clinical development plan supports cross-functional decisions, regulatory interactions, risk planning and trial delivery.
Learn more
Clinical Trial Trends Shaping Modern Drug Development
By Commercial Team
August 28, 2026
Explore clinical trial trends affecting the future of clinical trials, including DCTs, PROs, advanced therapies and outsourcing.
Learn more
The Analysis of Direct and Indirect Pathways in Observational Studies
By Statistical Consultancy Team
August 26, 2026
Understand direct vs indirect pathways in an AS observational study, including direct effect, indirect effect, binary mediators, and limitations.
Learn more
The Role of Data Monitoring Committees (DMC) in Clinical Trials
By Statistical Consultancy Team
August 21, 2026
A practical data monitoring committee overview covering DMC responsibilities, confidentiality, interim analysis and independent statistical support.
Learn more
Group Sequential Designs in Clinical Trials: A Practical Guide
By Statistical Consultancy Team
August 14, 2026
Understand group sequential designs, stopping boundaries, alpha spending and when interim looks are useful in clinical trials.
Learn more
What is Audit Trail Review in Clinical Trials?
By Clinical Data Management Team
August 11, 2026
See how audit trail review supports clinical trial oversight through proportionate scope, clear ownership, contextual review, and documented findings.
Learn more
How an SDTM Mapping Automation Tool Supports Data Standardisation
By Clinical Programming Team
August 7, 2026
Understand where an SDTM mapping automation tool can help, where human review is needed, and why metadata quality matters.
Learn more
AI in Clinical Trial Design for Study Teams and Sponsors
By Statistical Consultancy Team
July 30, 2026
How AI in clinical trial design can support feasibility, recruitment, data review, and governance when used with clear human oversight.
Learn more
Respiratory Clinical Trials Across Key Indications
By Statistical Consultancy Team
July 27, 2026
Understand how respiratory clinical trials differ across asthma, COPD, IPF, Long COVID, infections, and other respiratory diseases.
Learn more
1
2
3
4
5
Subscribe to the Blog